194 related articles for article (PubMed ID: 12777375)
21. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis.
Pedram A; Razandi M; Levin ER
Endocrinology; 2001 Apr; 142(4):1578-86. PubMed ID: 11250939
[TBL] [Abstract][Full Text] [Related]
22. Enhancement of ischemia-induced angiogenesis by eNOS overexpression.
Amano K; Matsubara H; Iba O; Okigaki M; Fujiyama S; Imada T; Kojima H; Nozawa Y; Kawashima S; Yokoyama M; Iwasaka T
Hypertension; 2003 Jan; 41(1):156-62. PubMed ID: 12511546
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor modulates skeletal myoblast function.
Germani A; Di Carlo A; Mangoni A; Straino S; Giacinti C; Turrini P; Biglioli P; Capogrossi MC
Am J Pathol; 2003 Oct; 163(4):1417-28. PubMed ID: 14507649
[TBL] [Abstract][Full Text] [Related]
24. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro.
van Nieuw Amerongen GP; Koolwijk P; Versteilen A; van Hinsbergh VW
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):211-7. PubMed ID: 12588761
[TBL] [Abstract][Full Text] [Related]
25. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
[TBL] [Abstract][Full Text] [Related]
26. Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S; Bayle M; Laïn G; Déléris G
Curr Med Chem Anticancer Agents; 2003 Mar; 3(2):95-117. PubMed ID: 12678905
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model.
Babaei S; Stewart DJ
Cardiovasc Res; 2002 Jul; 55(1):190-200. PubMed ID: 12062722
[TBL] [Abstract][Full Text] [Related]
28. Glucose-6-phosphate dehydrogenase overexpression decreases endothelial cell oxidant stress and increases bioavailable nitric oxide.
Leopold JA; Zhang YY; Scribner AW; Stanton RC; Loscalzo J
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):411-7. PubMed ID: 12615686
[TBL] [Abstract][Full Text] [Related]
29. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
30. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
Inoki I; Shiomi T; Hashimoto G; Enomoto H; Nakamura H; Makino K; Ikeda E; Takata S; Kobayashi K; Okada Y
FASEB J; 2002 Feb; 16(2):219-21. PubMed ID: 11744618
[TBL] [Abstract][Full Text] [Related]
31. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis.
Yoshida S; Ono M; Shono T; Izumi H; Ishibashi T; Suzuki H; Kuwano M
Mol Cell Biol; 1997 Jul; 17(7):4015-23. PubMed ID: 9199336
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
34. VEGF-induced permeability increase is mediated by caveolae.
Feng Y; Venema VJ; Venema RC; Tsai N; Behzadian MA; Caldwell RB
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):157-67. PubMed ID: 9888439
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.
Sengupta S; Gherardi E; Sellers LA; Wood JM; Sasisekharan R; Fan TP
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):69-75. PubMed ID: 12524227
[TBL] [Abstract][Full Text] [Related]
36. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability.
Eriksson A; Cao R; Roy J; Tritsaris K; Wahlestedt C; Dissing S; Thyberg J; Cao Y
Circulation; 2003 Mar; 107(11):1532-8. PubMed ID: 12654612
[TBL] [Abstract][Full Text] [Related]
37. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse.
Balasubramaniam V; Tang JR; Maxey A; Plopper CG; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2003 Jun; 284(6):L964-71. PubMed ID: 12588707
[TBL] [Abstract][Full Text] [Related]
38. Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor.
Nicosia RF; Lin YJ; Hazelton D; Qian X
Am J Pathol; 1997 Nov; 151(5):1379-86. PubMed ID: 9358764
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat.
Zhang R; Wang L; Zhang L; Chen J; Zhu Z; Zhang Z; Chopp M
Circ Res; 2003 Feb; 92(3):308-13. PubMed ID: 12595343
[TBL] [Abstract][Full Text] [Related]
40. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.
Enholm B; Karpanen T; Jeltsch M; Kubo H; Stenback F; Prevo R; Jackson DG; Yla-Herttuala S; Alitalo K
Circ Res; 2001 Mar; 88(6):623-9. PubMed ID: 11282897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
